ZIVO Bioscience, Inc. (ZIVOW)

OTCMKTS · Delayed Price · Currency is USD · Warrants
0.5500
0.00 (0.00%)
At close: Sep 2, 2025
Market Cap64.93M
Revenue (ttm)174.90K
Net Income (ttm)-9.72M
Shares Outn/a
EPS (ttm)-2.69
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume120
Average Volume5,376
Open0.5500
Previous Closen/a
Day's Range0.5500 - 0.5500
52-Week Range0.1200 - 2.3810
Betan/a
RSI46.94
Earnings DateNov 13, 2025

About ZIVO Bioscience

ZIVO Bioscience, Inc., together with its subsidiaries, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and ani... [Read more]

Industry Pharmaceutical Preparations
CEO John Payne
Employees 7
Stock Exchange OTCMKTS
Ticker Symbol ZIVOW
Full Company Profile

News

There is no news available yet.